CENPF and hepatocellular carcinoma: In addition, the overexpression of CENPF was closely related to poor OS in HCC patients with stage I-II (HR = 1.83, log rank P = 0.021, Figure 6D), stage II-III (HR = 2.37, log rank P = 3E-04, Figure 6E), and stage III-IV (HR = 2.36, log rank P = 0.0027, Figure 6F).